António José Cabrita Lucas Laires

  • 1413 Citations
  • 22 h-Index
1982 …2012
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where António José Cabrita Lucas Laires is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Quercetin Medicine & Life Sciences
Cytochrome P-450 CYP1A2 Medicine & Life Sciences
Mutagens Medicine & Life Sciences
Biotransformation Medicine & Life Sciences
Cytochrome P-450 Enzyme System Medicine & Life Sciences
Carcinogens Medicine & Life Sciences
Escherichia coli Chemical Compounds
Wine Chemical Compounds

Research Output at NOVA 1982 2012

5 Citations (Scopus)

DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells.

Dinis, J., Silva, V., Gromicho, M., Martins, C., Laires, A., Tavares, P., Rendeiro, P., Torres, F., Rueff, J. & Rodrigues, AS., 2012, In : Leukemia & Lymphoma. 53, 10, p. 2004-14 11 p.

Research output: Contribution to journalArticle

K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DNA Damage
DNA Repair
Protein-Tyrosine Kinases
15 Citations (Scopus)

Estragole: A weak direct-acting food-borne genotoxin and potential carcinogen

Martins, C., Cação, R., Cole, K. J., Phillips, D. H., Laires, A., Rueff, J. & Rodrigues, A. S., 2012, In : Mutation Research-Genetic Toxicology And Environmental Mutagenesis. 747, 1, p. 86-92 7 p.

Research output: Contribution to journalArticle

Mutagens
Carcinogens
Comet Assay
Food
DNA Adducts

Genomics and Cancer Drug Resistance

Rodrigues, A. S., Dinis, J., Gromicho, M., Martins, C., Laires, A. & Rueff, J., 1 Jan 2012, In : Current Pharmaceutical Biotechnology. 13, 5, p. 651-673

Research output: Contribution to journalArticle

3 Citations (Scopus)